Virtual Library

Start Your Search

  • WCLC 2017

    18th World Conference on Lung Cancer

    Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan

    Presentation Date(s):  
    • Oct 15 - 18, 2017
    • Total Presentations: 2295

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Download PDF of the Conference Program: Click Here.
    Onsite Conference Program Addendum (17/10/2017): Click Here.
    Download PDF of the Abstract Book: Click Here.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    P1.03 - Chemotherapy/Targeted Therapy

    • Type: Poster Session with Presenters Present
    • Track: Chemotherapy/Targeted Therapy
    • Presentations: 53
    • +

      P1.03-001 - Verification and Implementation of the VENTANA Anti-ALK D5F3 Antibody in Detecting ALK Rearrangement in NSCLC

      09:30 - 09:30  |  Author(s): N. Nadira

      • Abstract

      Loading...

    • +

      P1.03-002 - Crizotinib-Associated Toxic Epidermal Necrolysis in an ALK-Positive Advanced NSCLC Patient

      09:30 - 09:30  |  Presenter: Shaoyu Yang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-003 - Clinical Implications of an Analysis of Crizotinib Pharmacokinetics Co-Administered with Dexamethasone in Patients with NSCLC

      09:30 - 09:30  |  Presenter: Swan Lin

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-004 - Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status

      09:30 - 09:30  |  Presenter: Hirotsugu Kenmotsu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-005 - Phase 2 Study of Ceritinib in Patients with ALK+ NSCLC with Prior Alectinib Treatment in Japan: ASCEND-9

      09:30 - 09:30  |  Presenter: Hidehito Horinouchi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-006 - Clinicopathological Features and Poor Outcome for ALK Inhibitors of Squamous Cell Lung Cancer with ALK-Rearrangement

      09:30 - 09:30  |  Presenter: Hiroaki Motomura

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-007 - A Real-World Study of Clinicopathological Characteristics and Survival Outcome in Advanced ALK-Positive Non-Small-Cell Lung Cancer

      09:30 - 09:30  |  Author(s): Y. Jin

      • Abstract

      Loading...

    • +

      P1.03-008 - Analysis of Data on Interstitial Lung Disease Onset and Its Risk Following Treatment of ALK-positive NSCLC with Xalkori

      09:30 - 09:30  |  Presenter: Akihiko Gemma

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-009 - A Lung Adenocarcinoma with a STRN-ALK Rearrangement Was Poorly Responsive to Alectinib Treatment

      09:30 - 09:30  |  Presenter: Yuko Iida

      • Abstract

      Loading...

    • +

      P1.03-010 - Efficacy and Safety of Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors in ALK-Positive Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Reina Imase

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-011 - Clinical Outcomes Correlated with Percentage of Positive Anaplastic-Lymphoma Kinase Cells Tested by FISH Analysis in NSCLC.  

      09:30 - 09:30  |  Presenter: Katy Louise Clarke

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-012 - Using Computational Modeling to Simulate Clinical Response of ALK Inhibitors to G1202R ALK and Possible Mechanisms of Resistance

      09:30 - 09:30  |  Presenter: Chien-Ting Liu

      • Abstract

      Loading...

    • +

      P1.03-013 - Monitoring of ALK Fusions and Mutations in Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

      09:30 - 09:30  |  Presenter: Laura Mezquita

      • Abstract

      Loading...

    • +

      P1.03-014 - Saline Alone vs Saline plus Mannitol Hydration for the Prevention of Acute Cisplatin Nephrotoxicity: A Randomized Trial

      09:30 - 09:30  |  Presenter: Wilfred Dela Cruz

      • Abstract

      Loading...

    • +

      P1.03-015 - The Relationship between the UGT1A1*27 and UGT1A1*7 Genetic Polymorphisms and Irinotecan-Related Toxicities in Patients with Lung Cancer

      09:30 - 09:30  |  Presenter: Minoru Fukuda

      • Abstract

      Loading...

    • +

      P1.03-016 - Video-Thoracoscopic Pulmonary Resection Avoids Delay and Increase Adjuvant Chemotherapy Compliance for Non-Small Cell Lung Carcinoma

      09:30 - 09:30  |  Presenter: Ak?n Ozturk

      • Abstract

      Loading...

    • +

      P1.03-017 - Benzyl Isothiocyanate Induces Protective Autophagy in Human Lung Cancer Cells through Endoplasmic Reticulum Stress-Mediated Mechanism

      09:30 - 09:30  |  Author(s): Q. Zhang

      • Abstract

      Loading...

    • +

      P1.03-018 - Effectiveness of Supportive Care Drugs in Lung Cancer Patients Undergoing 1st Line Chemotherapy in a Resource Limited Setting

      09:30 - 09:30  |  Presenter: Digambar Behera

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-019 - Sophoridine Inhibits Lung Cancer Cell Proliferation through Activating Hippo Signaling and P53 Pathway

      09:30 - 09:30  |  Presenter: Jiangping Xiong

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-020 - Detection of Hypoxia Using EF5 PET/CT in 10 Patients with Advanced NSCLC Receiving Chemotherapy with and without Bevacizumab

      09:30 - 09:30  |  Presenter: Frederic Lacroix-Poisson

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-021 - A Prospective Observational Study to Evaluate Incidence of Thromboembolic Events during Platinum Based Chemotherapy in Lung Cancer

      09:30 - 09:30  |  Presenter: Vikas Talreja

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-022 - A Phase 1B Study of TRC105 in Combination with Paclitaxel/Carboplatin and Bevacizumab in Patients with Stage 4 Non-Squamous Cell Lung Cancer

      09:30 - 09:30  |  Author(s): Francisco Robert

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-023 - The Real-World Practice of Bevacizumab Plus Chemotherapy in Stage IV Lung Adenocarcinoma: A Single Institute Experience

      09:30 - 09:30  |  Presenter: Yen-Hao Chen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-024 - Efficacy of Carboplatin-Vinorelbine in Advanced NSCLC Patients at Persahabatan Hospital, Jakarta - Indonesia

      09:30 - 09:30  |  Presenter: Putu Ayu Diah

      • Abstract

      Loading...

    • +

      P1.03-025 - Combination Therapy with Carboplatin and Hyperoxia Synergistically Enhances Suppression of Benzo[a]Pyrene Induced Lung Cancer

      09:30 - 09:30  |  Presenter: Sang Haak Lee

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-026 - Interim Results of a Phase I Study of Nivolumab plus Nab-Paclitaxel/Carboplatin in Patients with NSCLC

      09:30 - 09:30  |  Presenter: Jonathan W. Goldman

      • Abstract

      Loading...

    • +

      P1.03-027 - Randomized Phase 2 Study Comparing CBDCA+PTX+BEV and CDDP+PEM+BEV in Treatment-Naïve Advanced Non-Sq NSCLC (CLEAR Study)

      09:30 - 09:30  |  Presenter: Shinji Atagi

      • Abstract

      Loading...

    • +

      P1.03-028 - A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Untreated Stage IV Squamous Cell Lung Cancers

      09:30 - 09:30  |  Presenter: Paul K. Paik

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-029 - Study of Plasma Homocysteine as a Marker of Toxicity and Depression in Patients Treated with Pemetrexed-Based Chemotherapy 

      09:30 - 09:30  |  Author(s): A.R. Minchom

      • Abstract

      Loading...

    • +

      P1.03-030 - Prognostic Impact of the Presence of COPD in Patients with NSCLC under Conventional Systemic Chemotherapy

      09:30 - 09:30  |  Presenter: Jin Woo Kim

      • Abstract

      Loading...

    • +

      P1.03-031 - Adherence and Feasibility of 2 Treatment Schedules of S-1 as Adjuvant Chemotherapy in Completely Resected Lung Cancer

      09:30 - 09:30  |  Presenter: Takaharu Kiribayashi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-032 - Observation of Durative Infusion Endostar Combined with Chemotherapy Within Vascular Normalization Period in Advanced NSCLC

      09:30 - 09:30  |  Author(s): Qing Zhou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-033 - Long-Term Outcome of Histoculture Drug Response Assay Guided Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Yoshimitsu Hirai

      • Abstract

      Loading...

    • +

      P1.03-034 - Therapeutic Effect of Novel Leucyl-tRNA Synthetase Inhibitor, B1206, in Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Eun Young Kim

      • Abstract

      Loading...

    • +

      P1.03-035 - Efficacy of Nintedanib and Docetaxel in Combination with the Nutraceutical Use of Silibinin in Advanced NSCLC

      09:30 - 09:30  |  Presenter: Joaquim Bosch Barrera

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-036 - Adjuvant Chemotherapy with Uracil-Tegafur for Pathological T1aN0M0 Lung Adenocarcinoma with Lymphatic Vessel Invasion

      09:30 - 09:30  |  Presenter: Yoshitaka Kitamura

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-037 - A Phase II Study of Adjuvant Chemotherapy with Docetaxel plus Nedaplatin for Completely Resected Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Koji Teramoto

      • Abstract

      Loading...

    • +

      P1.03-038 - A Phase I Trial of Afatinib and Bevacizumab in Untreated Patients with Advanced NSCLC Harboring EGFR-Mutations: OLCSG1404

      09:30 - 09:30  |  Presenter: Shoichi Kuyama

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-039 - Therapeutic Inhibition of the Cancer Stem Cell Marker, ALDH1, a Promising Mechanism by Which Cisplatin Sensitivity Can Be Restored in NSCLC

      09:30 - 09:30  |  Author(s): L. Mac Donagh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-040 - Smokers Having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment - Single Center Experience

      09:30 - 09:30  |  Author(s): O. Ercelep

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-041 - Exploitation of the Cancer Stem Cell Marker ALDH1 Within the Vitamin a/Retinoic Acid Axis Promotes Re-Sensitisation of Cisplatin Resistant NSCLC

      09:30 - 09:30  |  Author(s): L. Mac Donagh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-042 - BBI608, a Small Molecule Stemness Inhibitor, Circumvents Cisplatin Resistance in NSCLC

      09:30 - 09:30  |  Author(s): L. Mac Donagh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-043 - 30-Day Mortality Following Systemic Anti-Cancer Treatment for NSCLC at a Single Canadian Cancer Centre

      09:30 - 09:30  |  Author(s): A.J.W. Gibson

      • Abstract

      Loading...

    • +

      P1.03-044 - Exploratory Analysis of Lung Cancer Patients in a Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) plus Gemcitabine

      09:30 - 09:30  |  Presenter: Lyudmila Bazhenova

      • Abstract

      Loading...

    • +

      P1.03-045 - HER-2 Mutation Is Not a Prognostic Factor Treated with First-Line Chemotherapy in NSCLC Patients

      09:30 - 09:30  |  Author(s): C. Zhao

      • Abstract

      Loading...

    • +

      P1.03-046 - A Retrospective Analysis of Correlation Between Cytokines in TME and Therapeutic Effect of Advanced Lung Cancer Chemotherapy in China

      09:30 - 09:30  |  Author(s): J. Shen

      • Abstract

      Loading...

    • +

      P1.03-047 - Carboplatin/ Weekly Nab-PTX in Elderly Patients with Previously Untreated Advanced Squamous NSCLC Selected Based on MNA-SF

      09:30 - 09:30  |  Presenter: So Takata

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-048 - miR-34a and the Micromanagement of Cancer Stemness and Resistance in NSCLC. Does It Hold Therapeutic Benefit?

      09:30 - 09:30  |  Author(s): L. Mac Donagh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-049 - Phase II Study of S-1 plus Bevacizumab Combination Therapy for Patients Previously Treated for Non-Squamous Non–Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Kentaro Masuhiro

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-050 - Clinical Consequences, Quality of Life, and Management of Neutropenic NSCLC Patients in the REVEL Trial

      09:30 - 09:30  |  Presenter: David S Ettinger

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-051 - Development of a Novel Microfluidic Device for Studying the Chemotaxis Mechanism of Bacterial Cancer Targeting

      09:30 - 09:30  |  Author(s): J. Song

      • Abstract

      Loading...

    • +

      P1.03-052 - Comparing EGFR-TKI with EGFR-TKI plus Chemotherapy as 1st Line Treatment in Advanced NSCLC Patients with Both Mutated EGFR and Bim Polymorphism

      09:30 - 09:30  |  Presenter: Yayi He

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.03-053 - Taiwan Real Word Efficacy of 1st Line EGFR TKIs Treatment in EGFR Mutation Positive Advanced Non Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Chih-Yen Tu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.04 - Clinical Design, Statistics and Clinical Trials

    • Type: Poster Session with Presenters Present
    • Track: Clinical Design, Statistics and Clinical Trials
    • Presentations: 13
    • +

      P1.04-001 - Osimertinib with Ramucirumab or Necitumumab in Advanced T790M-positive EGFR-Mutant NSCLC: Preliminary Ph1 Study Results

      09:30 - 09:30  |  Presenter: Helena Yu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-002 - Tolerability of Osimertinib and Its Impact on Quality of Life in Advanced Non-Small Cell Lung Cancer Patients: The ARPA Study

      09:30 - 09:30  |  Presenter: Enrica Capelletto

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-003 - The International Lung Screen Trial: A Multi-Centre Study to Evaluate LDCT Screening Selection Criteria and Nodule Management

      09:30 - 09:30  |  Presenter: Kuan Pin Lim

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-004 - Phase I/Ib Study of Nivolumab and Veliparib in Advanced Solid Tumors and Lymphoma with and without Alterations in Selected DNA Repair Genes

      09:30 - 09:30  |  Author(s): Y.K. Chae

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-005 - Phase 2 Study of Nivolumab and Metformin in Advanced Non-Small Cell Lung Cancer with and without Prior Treatment with PD-1/PD-L1 Inhibitors

      09:30 - 09:30  |  Author(s): Y.K. Chae

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-006 - Rovalpituzumab Tesirine vs Topotecan in Patients with Advanced Small Cell Lung Cancer Following 1st Line Chemotherapy

      09:30 - 09:30  |  Presenter: Philip Komarnitsky

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-007 - Rovalpituzumab Tesirine Maintenance Therapy Following 1st Line Platinum-Based Chemotherapy Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Philip Komarnitsky

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-008 - POSEIDON: A Phase 3 Study of First-Line Durvalumab ± Tremelimumab + Chemotherapy vs Chemotherapy Alone in Metastatic NSCLC

      09:30 - 09:30  |  Presenter: Tony SK Mok

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-009 - The First Study of BBSKE in Heavy Treated Advanced EGFR Wild Type and ALK Negative, Trxr1 High Expression NSCLC Patients.

      09:30 - 09:30  |  Presenter: Yongchang Zhang

      • Abstract

      Loading...

    • +

      P1.04-010 - CheckMate 870: An Open-label Safety Study of Nivolumab in Previously Treated Patients With Non-Small Cell Lung Cancer in Asia

      09:30 - 09:30  |  Presenter: Shun Lu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-011 - Development of Novel Blood-Based Biomarker Assays in 1L Advanced/ Metastatic NSCLC: Blood First Assay Screening Trial (BFAST)

      09:30 - 09:30  |  Presenter: Tony SK Mok

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-012 - A Phase 1b Dose-Escalation Study of TRC105 in Combination with Nivolumab  in Patients with Metastatic Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Author(s): Francisco Robert

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-013 - Phase 1b Multi-Indication Study of the Antibody Drug Conjugate Anetumab Ravtansine in Patients with Mesothelin-Expressing Advanced or Recurrent Malignancies

      09:30 - 09:30  |  Presenter: Alex Adjei

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.05 - Early Stage NSCLC

    • Type: Poster Session with Presenters Present
    • Track: Early Stage NSCLC
    • Presentations: 26
    • +

      P1.05-001 - Microwave Ablation plus Recombinant Human Endostatin (Endostar) versus Microwave Ablation Alone in Inoperable Stage I Non Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Guanghui Huang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-002 - Characteristics and Prognosis of Ground Glass Opacity Predominant Primary Lung Cancer Larger Than 3.0 Cm on Thin-Section Computed Tomography

      09:30 - 09:30  |  Presenter: Shigeki Suzuki

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-003 - Impact of Coexisting Pulmonary Diseases on Oncological Outcomes of Patients with pStage I Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Hiroyuki Tao

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-004 - Adenocarcinoma Subtyping of Early Stage Lung Cancer in a Danish Cohort

      09:30 - 09:30  |  Presenter: Petrine laier Sonne

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-005 - Percutaneous Cryoablation for Lung Cancer Patients with Idiopathic Pulmonary Fibrosis

      09:30 - 09:30  |  Presenter: Takashi Ohtsuka

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-006 - Clinicopathological Features of Small-Sized Peripheral Squamous Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Takayuki Kosaka

      • Abstract

      Loading...

    • +

      P1.05-007 - A Retrospective Study to Compare Resection Rate and Survival Rate in Operable Stage I to III NSCLC After Introduction of Lung Cancer MDT

      09:30 - 09:30  |  Presenter: Ying Ying Sum

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-008 - A Comparison of the Imaging Features of Early Stage Primary Lung Cancer in Patients Treated with Surgery, SABR and Microwave Ablation 

      09:30 - 09:30  |  Presenter: Ambika Talwar

      • Abstract

      Loading...

    • +

      P1.05-009 - Analysis of Postoperative Prognosis in Terms of the Difference Between the Invasive Growth Area and the Total Tumor Diameter

      09:30 - 09:30  |  Presenter: Masaya Yotsukura

      • Abstract

      Loading...

    • +

      P1.05-010 - Curative Treatment Rates for Patients Diagnosed with Early Stage Non-Small Cell Lung Cancer (NSCLC) in England

      09:30 - 09:30  |  Author(s): A. Khakwani

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-011 - Comparison of Tumor Measurement Methods in Patients with Clinical Stage IA Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Takuya Nagashima

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-012 - Treatment Planning in Non-Small Cell Lung Cancer Shows Variable Utilization of Multidisciplinary Tumor Board

      09:30 - 09:30  |  Presenter: Joshua Robert Rayburn

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-013 - Induction Chemoradiation Is Associated with Improved Survival in Resected Non-Pancoast Lung Cancer with Chest Wall Invasion

      09:30 - 09:30  |  Author(s): J.A. Munoz-Largacha

      • Abstract

      Loading...

    • +

      P1.05-014 - Efficacy of Adjuvant Chemotherapy for Completely Resected Stage IB Non-Small Cell Lung Cancer 

      09:30 - 09:30  |  Author(s): Min Kwang Byun

      • Abstract

      Loading...

    • +

      P1.05-015 - Major Pathological Response as a Predictive Value of Survival in Early-Stage NSCLC  After Chemotherapy: Cohort of NATCH Phase III Trial

      09:30 - 09:30  |  Presenter: Enric Carcereny

      • Abstract

      Loading...

    • +

      P1.05-016 - The Prognosticator in Synchronous Multiple Primary Lung Cancer: A Comprehensive Analysis of 438 Cases

      09:30 - 09:30  |  Presenter: Yi Liu

      • Abstract

      Loading...

    • +

      P1.05-017 - Prognostic Significance of Preoperative Plasma D-Dimer Level in Patients with Surgically Resected Clinical Stage I Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Kaoru Kaseda

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-018 - Prognostic Impact of Tumor Shadow Disappearance Rate in Patients with Clinical IA Lung Adenocarcinoma

      09:30 - 09:30  |  Presenter: Joji Samejima

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-019 - Effects of Tumor Stroma and Inflammation on Survival of Stage I-IIp Lung Cancer

      09:30 - 09:30  |  Author(s): L. Millares

      • Abstract

      Loading...

    • +

      P1.05-020 - Clues of Stromal Invasion of Pulmonary Adenocarcinoma on CT, Focusing on Cicatricial Change

      09:30 - 09:30  |  Presenter: Ye Kyeong Jun

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-021 - Are Prognostic Factors Different from That Which Predicts Recurrence in Completely Resected Pathological Stage IB Adenocarcinoma?

      09:30 - 09:30  |  Presenter: Hiroyuki Ito

      • Abstract

      Loading...

    • +

      P1.05-022 - Association Between Neutrophil/Lymphocyte Ratio and Lymphocyte/Monocyte Ratio with Disease Free Survival in Operated NSCLC Patients in Peru

      09:30 - 09:30  |  Presenter: Rodrigo Motta

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-022a - Positive Pleural Lavage Cytology Is the Independent Prognostic Factor in Lung Cancer Patients with Pathological Stage I Disease

      09:30 - 09:30  |  Presenter: Tomoko So

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.05-022b - Identifying Novel Markers of Early Stage Lung Cancer Using a CRISPR/Cas9 Mouse Model

      09:30 - 09:30  |  Presenter: Paola A Marignani

      • Abstract

      Loading...

    • +

      P1.05-022c - Screening for Psychosocial Distress in Lung Cancer: Defining the Unmet Gaps

      09:30 - 09:30  |  Presenter: Rob Stirling

      • Abstract

      Loading...

    • +

      P1.05-022d - Lung Cancer in the Innocent Isn't so Innocent

      09:30 - 09:30  |  Author(s): U. Ahmad

      • Abstract

      Loading...

  • +

    P1.06 - Epidemiology/Primary Prevention/Tobacco Control and Cessation

    • Type: Poster Session with Presenters Present
    • Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
    • Presentations: 24
    • +

      P1.06-001 - Does Access to Private Health Care Influence Potential Lung Cancer Cure Rates?

      09:30 - 09:30  |  Presenter: Thadathilankal Jess John

      • Abstract

      Loading...

    • +

      P1.06-002 - The Role of Comorbidity in the Management and Prognosis in Nonsmall Cell Lung Cancer: A Population-Based Study

      09:30 - 09:30  |  Presenter: Jonas Nilsson

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-003 - Preoperative Physical Function and Activity in Elderly Lung Cancer Patients Compared to General Elderly

      09:30 - 09:30  |  Presenter: Sunga Kong

      • Abstract

      Loading...

    • +

      P1.06-004 - Occurrence of Lung Cancer among Young Patients Below the Age of 50 – A Retrospective Analysis

      09:30 - 09:30  |  Presenter: Anna Maria Romaszko-Wojtowicz

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-005 - Sex-Based Disparities in NSCLC: An Evidence-Based Study 

      09:30 - 09:30  |  Presenter: Noor Asaad Alsaadoun

      • Abstract

      Loading...

    • +

      P1.06-006 - Survival Benefits and Associated Prognostic Factors among Young NSCLC Patients

      09:30 - 09:30  |  Author(s): A. D'Silva

      • Abstract

      Loading...

    • +

      P1.06-007 - EGFR Status Evaluation and Epidemiological Profile in Patients with NSCLC in a Brazilian Public Health Instituition

      09:30 - 09:30  |  Author(s): C.D.S.M. Emerich

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-008 - Prevalence of Lung Cancer in Patients with Interstitial Lung Disease is Higher than in those with Chronic Obstructive Pulmonary Disease

      09:30 - 09:30  |  Presenter: Wonil Choi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-009 - Barriers to Clinical Trial Participation in Lung Cancer Patients, a Single Institution Experience

      09:30 - 09:30  |  Author(s): C.L. Geiger

      • Abstract

      Loading...

    • +

      P1.06-010 - Interaction between Treatment Delivery Delay and Stage on the Mortality from Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Fernando Conrado Abrão

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-011 - Hyponatremia - Evaluation of Prevalence in Hospitalized Lung Cancer Patients and Its Prognostic Significance

      09:30 - 09:30  |  Presenter: Sharif Ahmed

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-012 - Non-Small Cell Lung Cancer (NSCLC) Patient Characteristics and Clinical Care Insights in Sweden: The SCAN-LEAF Study

      09:30 - 09:30  |  Presenter: Martin Sandelin

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-013 - Latent Tuberculosis in Newly Diagnosed Lung Cancer Patients. An Spanish Prospective Study

      09:30 - 09:30  |  Author(s): E. Martinez Moreno

      • Abstract

      Loading...

    • +

      P1.06-014 - Higher Body Mass Index Prolongs Survival Time in Non-Small Cell Lung Cancer with Good Performance Status

      09:30 - 09:30  |  Presenter: Tomohiro Suzumura

      • Abstract

      Loading...

    • +

      P1.06-015 - Analysis of Relationship Between Non-Small Cell Lung Cancer and Nicotine Dependence

      09:30 - 09:30  |  Presenter: Yoon Ho Ko

      • Abstract

      Loading...

    • +

      P1.06-016 - Route to Lung Cancer Diagnosis in the UK: How Does This Affect Patient Outcome? 

      09:30 - 09:30  |  Presenter: Sher May Ng

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-017 - Lung Cancer Detection Rates for National Comprehensive Cancer Network Group 2 High Risk Individuals

      09:30 - 09:30  |  Presenter: Andrea Katalin Borondy Kitts

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-018 - EGFR Mutations and ALK Gene Rearrangements: Changing Patterns of Molecular Testing in Brazil

      09:30 - 09:30  |  Author(s): S. Palacio

      • Abstract

      Loading...

    • +

      P1.06-019 - The Association Between HPV Presence and EGFR Mutations in Asian Patients with NSCLC: A Meta-Analysis

      09:30 - 09:30  |  Presenter: Hengrui Liang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-020 - Unequal Access to Health Care System Have a Higher Impact in Upgrading Staging for 8th TNM Ed

      09:30 - 09:30  |  Presenter: Maria Teresa Ruiz Tsukazan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-021 - Lung Cancer Among Women Assisted in an Argentinean University Institution

      09:30 - 09:30  |  Presenter: Carolina Gabay

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.06-022 - Prognostic Value of NLR in Overall Survival of Patients with Advanced Lung Cancer

      09:30 - 09:30  |  Presenter: Claudio Flores

      • Abstract

      Loading...

    • +

      P1.06-023 - Spatio-Temporal Distribution of Lung Cancer Mortality Rate in Peru: 2005-2014

      09:30 - 09:30  |  Presenter: Claudio J. Flores

      • Abstract

      Loading...

    • +

      P1.06-024 - Outcome of Non-Small Cell Lung Cancer Patients Treated in the Private Health Care in Brazil

      09:30 - 09:30  |  Author(s): Clarissa Baldotto

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.07 - Immunology and Immunotherapy

    • Type: Poster Session with Presenters Present
    • Track: Immunology and Immunotherapy
    • Presentations: 48
    • +

      P1.07-001 - Clinical Value of Expression of PD-L1 and CD8 of 58 Cases with NSCLC 

      09:30 - 09:30  |  Presenter: Hongnian Wu

      • Abstract

      Loading...

    • +

      P1.07-002 - The Expression of PD-L1 Protein as a Prognostic Factor in Lung Squamous Cell Carcinoma

      09:30 - 09:30  |  Presenter: Kazuki Takada

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-003 - Cytolitic Tests with Hyperimmune Patient Sera Is a Good Prognostic Tool in Racotumomab Immunotherapy in Advanced Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Necdet Ismail Hakk? Uskent

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-004 - Predictive Biomarkers of Response to Nivolumab in Non–Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study

      09:30 - 09:30  |  Presenter: Yuki Kataoka

      • Abstract

      Loading...

    • +

      P1.07-005 - A Systematic and Genome-Wide Correlation Analysis of PD-L1 Expression and Common NSCLC Driver Genes

      09:30 - 09:30  |  Presenter: Xiaoshun Shi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-006 - Altered Expression of Programmed Death-1 Receptor (PD-1) and Its Ligand PD-L1, PD-L2 after Neo-Adjuvant Chemotherapy in Lung Cancer

      09:30 - 09:30  |  Presenter: Wenyu Sun

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-007 - Interleukin-17A Promotes Lung Tumor Progression Through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade.  

      09:30 - 09:30  |  Presenter: Esra A Akbay

      • Abstract

      Loading...

    • +

      P1.07-008 - Microbiome & Immunotherapy: Antibiotic Use Is Associated with Inferior Survival for Lung Cancer Patients Receiving PD-1 Inhibitors

      09:30 - 09:30  |  Presenter: Jonathan R Thompson

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-009 - PD-L1 Expression in Circulating Tumor Cells and Response to PD-1 Inhibitor Treatment in Non-Small Cell Lung Cancer Patients

      09:30 - 09:30  |  Presenter: Nicolas Guibert

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-010 - Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab

      09:30 - 09:30  |  Presenter: Junko Tanizaki

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-011 - PD-L1 Expression and CD8+ T Cell Infiltration Associate with the Prognosis of Pulmonary Neuroendocrine Tumor

      09:30 - 09:30  |  Presenter: Haiyue Wang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-012 - Prediction Sensitivity of PD-1 Checkpoint Blockade Using Pathological Tissues Specimens by Novel Computerized Analysis System

      09:30 - 09:30  |  Presenter: Akira Saito

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-013 - Detection of Genomic Alterations in Plasma Circulating Tumor DNA in Patients with Metabolically Active Lung Cancers

      09:30 - 09:30  |  Author(s): Z. Yuan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-014 - Association of Preoperative Serum CRP with PD-L1 Expression in NSCLC: A Comprehensive Analysis of Systemic Inflammatory Markers

      09:30 - 09:30  |  Presenter: Takaki Akamine

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-015 - Interferon-Gamma (INFG) as a Biomarker to Guide Immune Checkpoint Blockade (ICB) in Cancer Therapy

      09:30 - 09:30  |  Presenter: Niki Karachaliou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-016 - Comparison of PD-L1 Immunohistochemical Staining between EBUS-TBNA and Resected Non-Small Cell Lung Cancer Specimens

      09:30 - 09:30  |  Presenter: Kenneth Kazuto Sakata

      • Abstract

      Loading...

    • +

      P1.07-017 - Assessment of Cancer Immunity Status in Each Patient Using Immunogram

      09:30 - 09:30  |  Presenter: Takahiro Karasaki

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-018 - A Meta-Analysis of PD-L1 Expression as a Biomarker of PD-1 Blockade in Advanced Non Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Johnathan Man

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-019 - Immune Cell Infiltrates in Non-Small Cell Lung Cancer and Interleukin-22 Expression

      09:30 - 09:30  |  Author(s): J. Stump

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-020 - Autoantibody Profiles of Cancer-Testis Genes in Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Dijana Djureinovic

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-021 - Multiplex Immune Profiling Identifies Prognostic Importance of the Spatial Co-Localization of Immune Cells in NSCLC

      09:30 - 09:30  |  Presenter: Artur Mezheyeuski

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-022 - Routine PD-L1 Immunohistochemistry Testing by 22C3 in a Canadian Reference Testing Centre

      09:30 - 09:30  |  Author(s): T. Albaqer

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-023 - The Correlation Between B7-H4 Expression and Survival of Non-Small Cell Lung Cancer Patients Treated with Nivolumab

      09:30 - 09:30  |  Author(s): C. Genova

      • Abstract

      Loading...

    • +

      P1.07-024 - ISEND May Predict Clinical Outcomes for Advanced NSCLC Patients on PD-1/PD-L1 Inhibitors but
      Not Chemotherapies or Targeted Kinase Inhibitors

      09:30 - 09:30  |  Presenter: Wungki Park

      • Abstract

      Loading...

    • +

      P1.07-025 - Correlating ISEND and Tumor Mutation Burden (TMB) with Clinical Outcomes of Advanced Non-Small Cell Lung Cancer (ANSCLC) Patients on Nivolumab

      09:30 - 09:30  |  Presenter: Wungki Park

      • Abstract

      Loading...

    • +

      P1.07-026 - Predicting Tumor Mutational Burden (TMB) and Tumor Neoantigen Burden (TNB) of East Asian ANSCLC Patients by a Targeted Genomic Profiling

      09:30 - 09:30  |  Presenter: Likun Chen

      • Abstract

      Loading...

    • +

      P1.07-027 - PD-L1 Expression Analysis in African American (AA) and Hispanic Lung Cancer Patients at a Minority-Based Academic Cancer Center

      09:30 - 09:30  |  Presenter: Elaine Shum

      • Abstract

      Loading...

    • +

      P1.07-028 - Determination of Soluble PD-L1 as a Potential Biomaker for Anti-PD(L)1 Therapy in Non-Small Cell Lung Cancer (NSCLC)

      09:30 - 09:30  |  Author(s): A. Barba Joaquín

      • Abstract

      Loading...

    • +

      P1.07-029 - Correlation Study Between Plasma sPD-L1 and the Efficacy and Prognosis of Patients with Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Xiaoyan Kang

      • Abstract

      Loading...

    • +

      P1.07-030 - Prognostic Impact of PD-L1 Expression in Correlation with HLA Class I Expression Status in Adenocarcinoma of the Lung

      09:30 - 09:30  |  Presenter: Kazue Yoneda

      • Abstract

      Loading...

    • +

      P1.07-031 - Autoantibodies Associated with Risk of Subclinical Autoimmunity and Immune-Related Adverse Events from Checkpoint Inhibitor Therapy

      09:30 - 09:30  |  Presenter: David E Gerber

      • Abstract

      Loading...

    • +

      P1.07-032 - 28-Color, 30 Parameter Flow Cytometry to Dissect the Complex Heterogeneity of Tumor Infiltrating T Cells in Lung Cancer

      09:30 - 09:30  |  Author(s): J. Brummelman

      • Abstract

      Loading...

    • +

      P1.07-033 - Differential Expression of Immune Inhibitory Markers in Association with the Immune Microenvironment in Resected Lung Adenocarcinomas

      09:30 - 09:30  |  Presenter: Mingjuan Lisa Zhang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-034 - Pretreatment Neutrophil & Platelet Count as a Predictor for Unfavorable Clinical Outcome in Non-Small Cell Lung Cancer (NSCLC) 

      09:30 - 09:30  |  Presenter: Sarita Agte

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-035 - Lymphocytes and Neutrophils Count After Two Cycles and TTF1 Expression as Early Outcome Predictors During Immunotherapy

      09:30 - 09:30  |  Presenter: Iosune Baraibar

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-036 - LC-HRMS Metabolomics Profiling in Advanced NSCLC Treated with Anti PD-1 Agents. Metabolic Features at Diagnosis and at Response Evaluation

      09:30 - 09:30  |  Presenter: Ana Laura Ortega Granados

      • Abstract

      Loading...

    • +

      P1.07-037 - Testing the Positive and Negative Immune Checkpoint on PBMCs of Patients from Initiatory to Terminative Treatment of Anti PD-1 Antibody

      09:30 - 09:30  |  Presenter: Wushuang Du

      • Abstract

      Loading...

    • +

      P1.07-038 - The Potential Clinical Application of Comprehensive Genomic Profiling in Targeted Therapy and Immunotherapy of Lung Cancer

      09:30 - 09:30  |  Presenter: Mingwu Chen

      • Abstract

      Loading...

    • +

      P1.07-039 - Blood Biomarkers Correlate with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti PD-1 Antibodies

      09:30 - 09:30  |  Author(s): A.E. Soyano

      • Abstract

      Loading...

    • +

      P1.07-040 - Prognosis-Relevant Subgroups in NSCLC According to Granulocytic Myeloid-Derived Suppressor Cell Frequency and Cytokine Levels

      09:30 - 09:30  |  Author(s): Lourdes Barrera

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-041 - CD47 Expression and Prognosis in a Cohort of Patients with Lung Adenocarcinoma (NSCLC)

      09:30 - 09:30  |  Presenter: Oscar Arrieta

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-042 - PD-L1 and CD8 Expression in EGFR-Mutant or ALK-Rearranged Patients with Lung Cancer

      09:30 - 09:30  |  Author(s): S. Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-043 - Barrier Molecule Overexpression is Associated with Increased CD8 T Cells and Decreased B/Treg Cells in Human Lung Cancer

      09:30 - 09:30  |  Author(s): Young Kwang Chae

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-044 - The Impact of Neutrophil/Lymphocyte Ratio as the Predictive Marker to Anti-PD-1 Antibody Treatment in NSCLC Patients

      09:30 - 09:30  |  Presenter: Keiko Tanimura

      • Abstract

      Loading...

    • +

      P1.07-044a - Comparison of Tumor Mutational Burden (TMB) Derived from Whole Exome and Large Panel Sequencing in Lung Cancer

      09:30 - 09:30  |  Author(s): G. Shan

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-044b - Pretreatment Neutrophil/Lymphocyte Ratio and the Efficacy of Nivolumab Treatment in Non–Small-Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Hiroshi Kobayashi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-044c - Neurological Complications Following Treatment with Anti-PD1 Immune Checkpoint Inhibitors

      09:30 - 09:30  |  Author(s): R. Mason

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.07-044d - Positive Conversion of the PD-L1 Expression after Treatments with Chemotherapy and Nivolumab

      09:30 - 09:30  |  Presenter: Naoki Haratake

      • Abstract

      Loading...

  • +

    P1.08 - Locally Advanced NSCLC

    • Type: Poster Session with Presenters Present
    • Track: Locally Advanced NSCLC
    • Presentations: 10
    • +

      P1.08-001 - Surgical versus Non-Surgical Treatments for Resectable Stage III NSCLC: A Systematic Review and Meta-Analysis

      09:30 - 09:30  |  Author(s): Y.Y. Soon

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.08-002 - Blood Supply to the Tumor Do Not Predict the Effect of Induction Therapy in Patients with Locally Advanced Lung Cancer

      09:30 - 09:30  |  Presenter: Koji Kawaguchi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.08-003 - Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable, Stage III Non-Small Cell Lung Cancer: A Phase I Study

      09:30 - 09:30  |  Presenter: Kristin A Higgins

      • Abstract

      Loading...

    • +

      P1.08-004 - Adjuvant Chemoradiotherapy vs. Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Jong-Mu Sun

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.08-005 - Preoperative Analysis of 18FDG-PET Features May Predict Loco-Regional Invasiveness in NSCLC

      09:30 - 09:30  |  Presenter: Pietro Bertoglio

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.08-006 - Phase I/II Study of Carboplatin, nab-paclitaxel, and Concurrent Radiation Therapy for Patients with Locally Advanced NSCLC.

      09:30 - 09:30  |  Presenter: Yuko Kawano

      • Abstract

      Loading...

    • +

      P1.08-007 - Surgery versus Concurrent Chemoradiotherapy for Resectable CIIIA-N2 NSCLC: A Propensity Score Matched Analysis

      09:30 - 09:30  |  Presenter: Xin Sun

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.08-008 - Chemoradiotherapy in the Regime of Accelerated Fractionation in the Treatment of Lung Cancer

      09:30 - 09:30  |  Author(s): D. Gogolin

      • Abstract

      Loading...

    • +

      P1.08-009 - Neutrophilia as Prognostic Biomarker in Locally Advanced Stage III Lung Cancer

      09:30 - 09:30  |  Author(s): A. Schernberg

      • Abstract

      Loading...

    • +

      P1.08-010 - Unsuspected N2 Disease in Patients Undergoing Surgery for Non-Small Cell Lung Cancer: Role of Extent and Location of the Lymph Node Metastasis

      09:30 - 09:30  |  Presenter: Saana Andersson

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.09 - Mesothelioma

    • Type: Poster Session with Presenters Present
    • Track: Mesothelioma
    • Presentations: 13
    • +

      P1.09-001 - Multiplexed Biomarker Strategies Based on Targeted Proteomics for Detection of Malignant Pleural Mesothelioma in Blood

      09:30 - 09:30  |  Presenter: Ferdinando Cerciello

      • Abstract

      Loading...

    • +

      P1.09-002 - Cellular Noise and Positional Effects Determine the Cell Stem State in Malignant Mesothelioma

      09:30 - 09:30  |  Presenter: Walter Blum

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.09-003 - Malignant Mesothelioma Versus Synovial Sarcoma: An Analysis of 19 Cases with Molecular Diagnosis

      09:30 - 09:30  |  Presenter: Sonja Klebe

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.09-004 - YB-1 Suppresses miR-137 via a Feed Forward Loop, Increasing YB-1 Levels, Migration and Invasion in Malignant Mesothelioma

      09:30 - 09:30  |  Presenter: Karin Schelch

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.09-005 - Targeting YB-1 Induces Either Drug Sensitisation or Resistance via Distinct Mechanisms in Malignant Pleural Mesothelioma

      09:30 - 09:30  |  Presenter: Thomas George Johnson

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.09-006 - JMJ and BRD Domain Family Members in Malignant Pleural Mesothelioma: Potential Therapeutic Targets or Not?

      09:30 - 09:30  |  Presenter: Steven G. Gray

      • Abstract

      Loading...

    • +

      P1.09-007 - Targeting MET/TAM Receptors in Mesothelioma: Are Multi-TKIs Superior to Specific TKI?

      09:30 - 09:30  |  Presenter: Steven G. Gray

      • Abstract

      Loading...

    • +

      P1.09-008 - A 4-microRNA Signature in Serum Can Discriminate Between Non-Small-Cell Lung Cancer and Malignant Pleural Mesothelioma

      09:30 - 09:30  |  Presenter: Michaela B Kirschner

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.09-009 - Evaluation of a Combined MicroRNA-Clinical Score as Prognostic Factor for Malignant Pleural Mesothelioma

      09:30 - 09:30  |  Presenter: Michaela B Kirschner

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.09-010 - PD-L1 Reactivity of Tumor Cells Can Successfully Be Determined in Malignant Mesothelioma Effusions 

      09:30 - 09:30  |  Author(s): M. Mansour

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.09-011 - LUME-Meso Phase II/III Study: Nintedanib + Pemetrexed/Cisplatin in Chemo-Naïve Patients with Malignant Pleural Mesothelioma

      09:30 - 09:30  |  Presenter: Anne Tsao

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.09-012 - A Pre-Clinical Investigation of Intrapleural Curcumin Treatments as an Adjunct Therapy for Malignant Pleural Mesothelioma

      09:30 - 09:30  |  Presenter: Ashleigh Jean Hocking

      • Abstract

      Loading...

    • +

      P1.09-013 - Profiling Response to Chemotherapy in Malignant Pleural Mesothelioma Among Hispanics (MeSO-CLICaP)

      09:30 - 09:30  |  Presenter: Andrés F. Cardona

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.10 - Nursing/Palliative Care/Ethics

    • Type: Poster Session with Presenters Present
    • Track: Nursing/Palliative Care/Ethics
    • Presentations: 7
    • +

      P1.10-002 - Outcome of Pilot RCT in Lung Cancer Surgery Patients Receiving Either Preop Carbohydrate & Postop Nutritional Drinks or Water

      09:30 - 09:30  |  Presenter: Amy Kerr

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.10-003 - Synergy in Motion: Transferring Nursing Knowledge from Clinical Trials to Standard Therapy to Enhance Care and Communication

      09:30 - 09:30  |  Presenter: Dianne Zawisza

      • Abstract

      Loading...

    • +

      P1.10-004 - Testing Efficacy of a Pulmonary Rehabilitation Program for Post Lung Cancer Resection Surgery

      09:30 - 09:30  |  Presenter: Wei Ling Hsiao

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.10-005 - Generation of Symptom Burden Patient-Reported Outcomes for Patients with Lung Cancer

      09:30 - 09:30  |  Author(s): L.A. Williams

      • Abstract

      Loading...

    • +

      P1.10-006 - Adverse Events After First-Line Target Therapy for Non-Small Cell Lung Cancer Patients in a Case Management Model

      09:30 - 09:30  |  Presenter: Lin Zhi Xuan

      • Abstract

      Loading...

    • +

      P1.10-007 - Preparing Mesothelioma Patients for Treatment: Providing Psychosocial Support Networks

      09:30 - 09:30  |  Presenter: Gleneara Elizabeth Bates

      • Abstract

      Loading...

    • +

      P1.10-008 - Palliative Care and Hospice Resources are Underutilized in Patients with Advanced Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Joshua Robert Rayburn

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.11 - Patient Advocacy

    • Type: Poster Session with Presenters Present
    • Track: Patient Advocacy
    • Presentations: 4
    • +

      P1.11-001 - Economic Impact of Immune Checkpoint Inhibitor Therapy in Brazil and Strategies to Improve Access

      09:30 - 09:30  |  Presenter: Pedro Aguiar Jr

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.11-002 - Lung Cancer in Nonagenarian Patients

      09:30 - 09:30  |  Presenter: Cheng Chieh Hsu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.11-003 - A Personalized Navigation Program to Increase Clinical Trial Participation of Lung Cancer Patients 

      09:30 - 09:30  |  Author(s): A. Ciupek

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.11-004 - Impact of Liquid Biopsy on the Treatment of Low-Income Lung Cancer Patients

      09:30 - 09:30  |  Author(s): A.A. D'Souza

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.12 - Pulmonology/Endoscopy

    • Type: Poster Session with Presenters Present
    • Track: Pulmonology/Endoscopy
    • Presentations: 8
    • +

      P1.12-001 - Flexible Bronchoscopic Cryotherapy in Patients with Malignant Central Airway Obstruction

      09:30 - 09:30  |  Presenter: Sung Kyoung Kim

      • Abstract

      Loading...

    • +

      P1.12-002 - Nanoparticle Targeted Folate Receptor 1 Enhanced Photodynamic Therapy for Lung Cancer

      09:30 - 09:30  |  Presenter: Tatsuya Kato

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.12-003 - Photothermal Ablation of Lung Cancer by Low Power Near-Infrared Laser and Topical Injection of Indocyanine Green; A Preliminary Animal Study

      09:30 - 09:30  |  Presenter: Kentaro Hirohashi

      • Abstract

      Loading...

    • +

      P1.12-005 - Improvement of Performance Status After Therapeutic Bronchoscopy in Patients with Airway Malignancy: Single Center Experience

      09:30 - 09:30  |  Presenter: Thitiwat Sriprasart

      • Abstract

      Loading...

    • +

      P1.12-006 - The Efficacy of Electrocautery Using Wire Snare as the Primary Ablation Modality for Malignant and Benign Airway Obstruction

      09:30 - 09:30  |  Presenter: Masahiko Harada

      • Abstract

      Loading...

    • +

      P1.12-007 - Outcomes of Radiotherapy and Endoscopic Airway Stenting for Central Airway Obstruction in Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Author(s): C.R. Gilbert

      • Abstract

      Loading...

    • +

      P1.12-008 - Photodynamic Therapy for Peripheral Lung Cancers Using Composite-Type Optical Fiberscope of 1.0 mm in Diameter

      09:30 - 09:30  |  Presenter: Jitsuo Usuda

      • Abstract

      Loading...

    • +

      P1.12-009 - Experience with Fully Covered Metallic Stents in Patients with Malignant Airway Obstruction

      09:30 - 09:30  |  Author(s): R.M. Ortiz Comino

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.